Comparison of the effects of midazolam and omeprazole on patupilone pharmacokinetics, efficacy, and safety in patients with advanced cancers.

Trial Profile

Comparison of the effects of midazolam and omeprazole on patupilone pharmacokinetics, efficacy, and safety in patients with advanced cancers.

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Jan 2012

At a glance

  • Drugs Midazolam; Omeprazole; Patupilone
  • Indications Cancer
  • Focus Pharmacokinetics
  • Sponsors Novartis
  • Most Recent Events

    • 04 Jan 2012 New trial record
    • 01 Dec 2011 Results published in the Cancer Chemotherapy and Pharmacology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top